We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
-9.7%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$507M
AUM Growth
-$84M
Cap. Flow
-$11.4M
Cap. Flow %
-2.25%
Top 10 Hldgs %
25.56%
Holding
124
New
1
Increased
29
Reduced
72
Closed
8

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$1.75M
2
NDSN icon
Nordson
NDSN
+$940K
3
JNJ icon
Johnson & Johnson
JNJ
+$352K
4
AMAT icon
Applied Materials
AMAT
+$329K
5
CMI icon
Cummins
CMI
+$290K

Top Sells

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$835K
2
ABBV icon
AbbVie
ABBV
+$796K
3
VOD icon
Vodafone
VOD
+$535K
4
ZTS icon
Zoetis
ZTS
+$529K
5
ENB icon
Enbridge
ENB
+$497K

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 18.13%
3 Industrials 12.36%
4 Communication Services 10.98%
5 Consumer Staples 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$322B
$3.42M 0.67%
46,885
-1,436
-3% -$101K
EA icon
52
Electronic Arts
EA
$53B
$3.41M 0.67%
43,199
+2,260
+6% +$207K
BMY icon
53
Bristol-Myers Squibb
BMY
$133B
$3.3M 0.65%
63,507
-4,068
-6% -$219K
LH icon
54
Labcorp
LH
$25B
$3.29M 0.65%
30,279
+1,636
+6% +$219K
GSK icon
55
GSK
GSK
$104B
$3.26M 0.64%
68,330
-3,032
-4% -$149K
YUM icon
56
Yum! Brands
YUM
$41.8B
$3.21M 0.63%
34,906
-1,308
-4% -$117K
BUD icon
57
AB InBev
BUD
$170B
$3.2M 0.63%
48,578
-4,566
-9% -$349K
BRK.B icon
58
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.13M 0.62%
15,331
+396
+3% +$82.7K
AMAT icon
59
Applied Materials
AMAT
$403B
$2.87M 0.56%
87,530
+9,586
+12% +$329K
STZ icon
60
Constellation Brands
STZ
$22.2B
$2.85M 0.56%
17,739
+8,819
+99% +$1.75M
BAX icon
61
Baxter International
BAX
$13.5B
$2.82M 0.56%
42,776
+350
+0.8% +$23.5K
INTU icon
62
Intuit
INTU
$86.5B
$2.7M 0.53%
13,733
-35
-0.3% -$7.28K
MDLZ icon
63
Mondelez International
MDLZ
$79.5B
$2.66M 0.53%
66,546
-3,375
-5% -$144K
HUB.B
64
DELISTED
HUBBELL INC CL-B
HUB.B
$2.59M 0.51%
26,043
-1,750
-6% -$174K
PXD
65
DELISTED
Pioneer Natural Resource Co.
PXD
$2.38M 0.47%
18,079
+542
+3% +$82.8K
CELG
66
DELISTED
Celgene Corp
CELG
$2.35M 0.46%
36,709
-1,472
-4% -$109K
EMR icon
67
Emerson Electric
EMR
$83.9B
$2.35M 0.46%
39,268
-1,100
-3% -$74.2K
SNA icon
68
Snap-on
SNA
$21.2B
$2.28M 0.45%
15,675
-1,200
-7% -$190K
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.08M 0.41%
35,701
-6,050
-14% -$375K
KO icon
70
Coca-Cola
KO
$377B
$1.96M 0.39%
41,350
-5,400
-12% -$258K
GWR
71
DELISTED
Genesee & Wyoming Inc.
GWR
$1.8M 0.36%
24,362
-595
-2% -$47.7K
KHC icon
72
Kraft Heinz
KHC
$30.7B
$1.66M 0.33%
38,643
-8,376
-18% -$434K
GILD icon
73
Gilead Sciences
GILD
$162B
$1.57M 0.31%
25,174
+44
+0.2% +$3.08K
WTS icon
74
Watts Water Technologies
WTS
$11.5B
$1.44M 0.28%
22,375
-125
-0.6% -$8.98K
VOD icon
75
Vodafone
VOD
$36.3B
$1.25M 0.25%
64,756
-26,780
-29% -$535K

Similar funds

Jacobs & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Jacobs & Co held 124 positions worth $507M, down 14% from $591M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jacobs & Co's Q4 2018 filing shows 1 new, 29 increased, 72 reduced and 8 closed positions. Its largest new stake was Nordson: 7,653 shares worth $913K. The largest sale was Newell Brands, an estimated $835K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2018 buy was Nordson: 7,653 shares worth $913K.
  • Jacobs & Co added most to Constellation Brands in Q4 2018, an estimated $1.75M increase.
  • Jacobs & Co's biggest Q4 2018 reduction was Newell Brands, cutting an estimated $835K.
  • Jacobs & Co fully exited PG&E in Q4 2018, selling an estimated $347K.
  • Jacobs & Co's ten largest holdings make up 26% of its $507M portfolio in Q4 2018.
  • Jacobs & Co opened 1 new position and closed 8 in Q4 2018.
  • Jacobs & Co's portfolio value fell 14% quarter-over-quarter to $507M.

Based on Jacobs & Co's 13F filing for Q4 2018, filed 7 Feb 2019.